stockmarketproxy
/
GMEDNYSE SEC EDGAR

GLOBUS MEDICAL INC

Surgical & Medical Instruments & Apparatus·AUDUBON, PA·FY end 12/31·CIK 1237831
OverviewFinancialsCompensationGovernanceInsidersFilings

Board of Directors

10 members · 8 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
David C. PaulChair23y59CompNCG
Keith W. PfeilCEO and Director1y47NCG
David D. DavidarDirector23y60CompNCG
Daniel T. LemaitreDirector15y72CompAudit
Ann D. RhoadsDirector15y60AuditNCG
James R. TobinLead Independent Director11y81NCGComp
Stephen T. ZarrilliDirector7y64Audit
Robert A. DouglasDirector7y66Audit
Leslie V. NorwalkDirector3y60Audit
Daniel J. WoltermanDirector3y69Comp

Risk-factor diff

FY 2025 10-K vs. FY 2024
+90 new113 removed

Net-new paragraphs in the most recent 10-K's Item 1A. Companies rarely add risk language without a real reason — additions here are often a leading signal of management concerns.

NEW · FY 2025

Our sales and operating results may be negatively affected, and we may not grow if we are unable to compete successfully.

NEW · FY 2025

The proliferation of physician-owned distributorships (“PODs”) could result in increased pricing pressure on our products or harm our ability to sell our products to physicians.

NEW · FY 2025

There may be future changes in legal and regulatory requirements, and changes impacting the federal workforce and agency policies may impact our operations and product development.

NEW · FY 2025

Our future capital needs are uncertain, and we may need to raise funds in the future, and such funds may not be available on acceptable terms or at all.

NEW · FY 2025

Because of their significant stock ownership, our executive officers, and our directors and principal stockholders will be able to exert control over us and our significant corporate decisions.

+ 25 more new paragraphs not shown

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.